Share

April 17, 2018; 90 (16) Article

The most affected health domains after ischemic stroke

Irene L. Katzan, Nicolas R. Thompson, Ken Uchino, Brittany Lapin
First published March 28, 2018, DOI: https://doi.org/10.1212/WNL.0000000000005327
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
422

Share

Article Information

vol. 90 no. 16 e1364-e1371
DOI: 
https://doi.org/10.1212/WNL.0000000000005327
PubMed: 
29592886
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received July 11, 2017
  • Accepted in final form December 18, 2017
  • First Published March 28, 2018.

Article Versions

Copyright & Usage: 
© 2018 American Academy of Neurology

Author Disclosures

    1. Irene L. Katzan, MD, MS,
    2. Nicolas R. Thompson, MS,
    3. Ken Uchino, MD and
    4. Brittany Lapin, PhD, MPH
  1. Irene L. Katzan, MD, MS,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Editorial Board - Stroke (American Stroke Association), 2014-present Editorial Board - Circulation: Cardiovascular Quality & Outcomes (American Heart Association) 2013 - present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) Eli Lilly (2) Novartis Pharmaceuticals

    Research Support, Government Entities:

    1. (1) Ohio Department of Health - Physician Lead for the Ohio Paul Coverdell Stroke Registry, 2007-2020

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Nicolas R. Thompson, MS,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Novartis Pharmaceuticals has paid salary support to my institution for research outside the submitted work. Inspire Medical Systems has paid salary support to my institution for research outside the submitted work.

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Ken Uchino, MD and
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. ACP Journal Club, Associate Editor, 2013-2016.

    Patents:

    1. NONE

    Publishing Royalties:

    1. I have received royalties for my book "Acute Stroke Care," Cambridge University Press, 2011.

    Employment, Commercial Entity:

    1. I am an employee of the Cleveland Clinic.

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. National Institute of Neurological Disorders and Stroke, 5U10NS086532-05, 2017-

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. American Heart Association.

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Brittany Lapin, PhD, MPH
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Neurological Institute Center for Outcomes Research & Evaluation (I.L.K., N.R.T., B.L.), and Cerebrovascular Center (I.L.K., K.U.), Cleveland Clinic, OH.
  1. Correspondence
    Dr. Katzan Katzani{at}ccf.org
View Full Text

Article usage

Article usage: March 2018 to February 2023

AbstractFullPdfSource
Mar 2018461023Highwire
Apr 2018204313392Highwire
May 20185731432Highwire
Jun 2018193616Highwire
Jul 201813147Highwire
Aug 201812732Highwire
Sep 2018112107Highwire
Oct 201811353Highwire
Nov 20189898Highwire
Dec 2018117810Highwire
Jan 201988312Highwire
Feb 2019108024Highwire
Mar 201911624Highwire
Apr 2019105118Highwire
May 20198624Highwire
Jun 20197023Highwire
Jul 20194742Highwire
Aug 20198165Highwire
Sep 201912037Highwire
Oct 20198814Highwire
Nov 201910515Highwire
Dec 20195324Highwire
Jan 20206803Highwire
Feb 20207824Highwire
Mar 20208133Highwire
Apr 20206523Highwire
May 20207143Highwire
Jun 20206854Highwire
Jul 20206705Highwire
Aug 20206359Highwire
Sep 20205604Highwire
Oct 20209422Highwire
Nov 202018122Highwire
Dec 202014313Highwire
Jan 202110522Highwire
Feb 202110724Highwire
Mar 202113386Highwire
Apr 202111425Highwire
May 20216965Highwire
Jun 20216045Highwire
Jul 20219911Highwire
Aug 202110524Highwire
Sep 202110235Highwire
Oct 202111217Highwire
Nov 202110401Highwire
Dec 2021117263Highwire
Jan 202297344Highwire
Feb 20221083910Highwire
Mar 2022119363Highwire
Apr 202295385Highwire
May 2022210364Highwire
Jun 2022127302Highwire
Jul 202274364Highwire
Aug 20228414Highwire
Sep 20226941Highwire
Oct 202211520Highwire
Nov 202212753Highwire
Dec 20227722Highwire
Jan 202388152Highwire
Feb 202371283Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me

Recommended articles